Our data also demonstrate that PGQYD can increase anti-superoxide anion and plasma SOD levels and reduce NADPH oxidase activity in vascular tissue, suggesting that PGQYD can reduce blood pressure and delay vascular aging associated with hypertension and that the mechanism may involve the adjustment of parameters related to oxidative stress. Here, FMO5 is linked to Hypertension.